Creation of dialysis vascular access with normal flow increases brain natriuretic peptide levels

International Urology and Nephrology

Volumn 41, Issue 4, 2009, Pages 997-1002

  Malík, Jan ^a,b   Tuka, Vladimir ^a   Krupickova, Zdislava ^a   Chytilova, Eva ^a   Holaj, Robert ^a   Slavikova, Marcela ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b lékarské fakulty UK a VFN   (Czech Republic)

Author keywords

Brain natriuretic peptide; End stage renal disease; Heart failure; Hemodialysis; Vascular access

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; HEMOGLOBIN;

ADULT; ARTICLE; BLOOD FLOW; BODY WEIGHT; CLINICAL ARTICLE; DIALYSIS; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY FAILURE; MALE; PROTEIN BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; VASCULAR ACCESS;

EID: 77954563365     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-009-9544-y     Document Type: Article

References (22)

1. Collins AJ (2003) Cardiovascular mortality in end-stage renal disease. Am J Med Sci 325:163-167. doi:10.1097/ 00000441-200304000-00002
2. London GM (2003) Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 2:85-94. doi: 10.1046/j.1525-139X.2003. 16023.x (Pubitemid 37356820)
3. Jin H, Afonso L, Singh A, Migdal S, Spears J (2006) Case report: recurrent heart failure with preserved ejection fraction but markedly elevated BNP in a 51-year-old female on hemodialysis with oversized AV fistula. Int J Cardiol 110:429-430. doi:10.1016/j.ijcard.2005.11.062 (Pubitemid 43831228)
4. MacRae J, Pandeya S, Humen DP, Krivitski N, Lindsay R (2004) Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am J Kidney Dis 43(5):e17-e21. doi:10.1053/j.ajkd.2004.01.016
5. Anderson CB, Codd JR, Graff RA, Groce MA, Harter HR, Newton WT (1976) Cardiac failure and upper extremity arteriovenous dialysis fistulas. Arch Intern Med 136:292-297. doi:10.1001/archinte.136.3.292
6. Bourquelot P (2001) High flow-surgical treatment. Blood Purif 19:130-131
7. Ahmad M, Robert R, Bargman JM, Oreopoulos D (2008) Advantages of peritoneal dialysis in comparison to hemodialysis, in cardiac allograft recipients with end stage renal disease. Int Urol Nephrol 40(4):1083-1087. doi: 10.1007/s11255-008-9406-z
8. Taskapan MC, Senel S, Ulutas O et al (2007) Brain natriuretic peptide and P wave duration in dialysis patients. Int Urol Nephrol 39(2):603-608. doi:10.1007/s11255-007-9191-0 (Pubitemid 47054873)
9. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H (1991) Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87:402-1412. doi:10.1172/ JCI115146
10. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS (2002) B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Analysis from Breathing Not Properly (BNP) multinational study. Circulation 106:416-422. doi:10.1161/01.CIR.0000025242. 79963.4C
11. Mallamaci F, Zoccali C, Tripepi G, Benedetto FA, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Stancanelli B, Malatino LS, Investigators CREED (2001) The cardiovascular risk extended evaluation. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 59:1559-1566. doi:10.1046/j.1523-1755.2001. 0590041559.x
12. Sheen V, Bhalla V, Tulua-Tata BS, Bhalla MA, Weiss D, Chiu A, Abdeen O, Mullaney S, Maisel A (2007) The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. Am Heart J 153: 244e1-244e5
13. Iwashima Y, Horio T, Takami Y, Inenaga T, Nishikimi T, Takishita S, Kawano Y (2002) Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. Am J Kidney Dis 40:974-982. doi:10.1053/ajkd.2002.36329 (Pubitemid 35265477)
14. Malik J, Slavikova M, Malikova H, Maskova J (2002) Many clinically silent access stenoses can be identified by ultrasonography. J Nephrol 15:661-665
15. Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Gruenert A (1994) Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentration in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Investig 72(6):430-434. doi:10.1007/BF00180516
16. Lee SW, Song JH, Kim GA, Lim HJ, Kim MJ (2003) Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis 41:1257-1266. doi:10.1016/S0272-6386(03) 00358-5 (Pubitemid 36637982)
17. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, Cutrupi S, Giacone G, Bellanuova I, Cottini E, Malatino LS, Investigators Creed (2001) Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12:1508-1515
18. Malík J, Svobodová J, Tuka V, Mokrejsova M, Tesar V (2007) Dyslipidemia and anemia in chronically hemodialyzed patients. Prague Med Rep 108(2):177-184
19. Grossman W (1980) Cardiac hypertrophy: useful adaptation or pathological process? Am J Med 69:576-584. doi: 10.1016/0002-9343(80)90471-4 (Pubitemid 10018714)
20. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F (1996) Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50:600-608. doi:10.1038/ki.1996.355
21. Katz AM (1990) The cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Engl J Med 322:100-110
22. Chemla ES, Morsy M, Anderson L, Whitemore A (2007) Inflow reduction by distalization of anastomosis treats efficiently high-inflow high-cardiac output vascular access for hemodialysis. Semin Dial 20(1):68-72. doi:10.1111/ j.1525-139X.2007.00244.x